David W. Dowdy, Ph.D.
Affiliations: | 2008 | Johns Hopkins University, Baltimore, MD |
Area:
Epidemiology, Public HealthGoogle:
"David Dowdy"Cross-listing: PHTree
Parents
Sign in to add mentor| Chris Beyrer | grad student | 2008 | Johns Hopkins | |
| (Impact and cost -effectiveness of improved diagnostics for tuberculosis in high-burden countries.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Semitala FC, Kadota JL, Musinguzi A, et al. (2024) Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial. Plos Medicine. 21: e1004356 |
| Malhotra A, Ryckman TS, Johnson K, et al. (2024) Active case-finding of tuberculosis compared with symptom-driven standard of care: a modelling analysis. International Journal of Epidemiology. 53 |
| Cox SR, Erisa KC, Kitonsa PJ, et al. (2024) Accuracy of C-reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory Care Triage in Uganda. Annals of the American Thoracic Society |
| Kendall EA, Kitonsa PJ, Nalutaaya A, et al. (2023) Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community. Thorax |
| Sung J, Nantale M, Nalutaaya A, et al. (2023) Evidence for tuberculosis in individuals with Xpert Ultra "trace" sputum during screening of high-burden communities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Aschmann HE, Musinguzi A, Kadota JL, et al. (2023) Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment. Medrxiv : the Preprint Server For Health Sciences |
| Kasaie P, Pennington J, Gupta A, et al. (2023) The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Reid M, Agbassi YJP, Arinaminpathy N, et al. (2023) Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet (London, England) |
| Ross JM, Greene C, Bayer CJ, et al. (2023) Preventing tuberculosis with community-based care in an HIV-endemic setting: a modeling analysis. Medrxiv : the Preprint Server For Health Sciences |
| Katamba A, Gupta AJ, Turimumahoro P, et al. (2023) A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial. Bmc Public Health. 23: 1568 |